Connective tissue growth factor gene expression alters tumor progression in esophageal cancer
- PMID: 11910473
- DOI: 10.1007/s00268-001-0242-x
Connective tissue growth factor gene expression alters tumor progression in esophageal cancer
Abstract
The ability of cancer cells to initiate specific fibroblast reactions may subsequently determine tumor evolution. In the present study we examined the coordinated expression of transforming growth factor-beta-1 (TGF-beta1), its signaling receptors, and its downstream mediator-connective tissue growth factor (CTGF)--and their impact on tumor progression and fibrogenesis in esophageal carcinomas. Messenger ribonucleic acid (mRNA) expression of TGF-beta1, CTGF, TGF-beta receptor subtype I ALK5 (TbetaR-IALK5), and TGF-beta receptor type II (TbetaR-II) was studied by Northern blot analysis in esophageal cancer and the normal esophagus. By means of immunohistochemistry and Western blot analysis, the respective proteins were localized in the tissue samples and the protein content was quantitated. Northern blot analysis revealed 3-fold and 4-fold increases (p < 0.05) in TGF-beta1 and CTGF mRNA levels, respectively, in esophageal cancer in comparison with normal controls, whereas TbetaR-I mRNA levels were significantly decreased and TbetaR-II mRNA levels were unchanged in the cancer samples. Immunostaining revealed results similar to those seen on the RNA level. TGF-beta1 and CTGF immunoreactivity were increased, TbetaR-II was unchanged, and TbetaR-IALK5 immunoreactivity was decreased. CTGF immunoreactivity was mainly present in the stroma surrounding the cancer cells but was also present in the cancer cells. The degree of fibrosis was different in squamous and adenocarcinomas and was significantly related to CTGF mRNA expression levels. The presence of CTGF in squamous cell carcinomas was associated with longer survival, whereas in adenocarcinomas it influenced survival negatively. The findings indicate that TGF-beta signaling is disturbed in esophageal cancer. CTGF, a downstream effector of TGF-beta action, differentially influences the composition of tumor microenvironment and distinct cell-matrix interactions in the two histological types of esophageal carcinoma, resulting in differences in tumor progression and patient survival.
Similar articles
-
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.Ann Surg. 1999 Jul;230(1):63-71. doi: 10.1097/00000658-199907000-00010. Ann Surg. 1999. PMID: 10400038 Free PMC article.
-
Connective tissue growth factor in human liver cirrhosis.Liver. 2000 Jul;20(4):296-304. doi: 10.1034/j.1600-0676.2000.020004296.x. Liver. 2000. PMID: 10959808
-
Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.Ann Surg. 2002 Jan;235(1):60-7. doi: 10.1097/00000658-200201000-00008. Ann Surg. 2002. PMID: 11753043 Free PMC article.
-
Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.Cytokine Growth Factor Rev. 1997 Sep;8(3):171-9. doi: 10.1016/s1359-6101(97)00010-5. Cytokine Growth Factor Rev. 1997. PMID: 9462483 Review.
-
Connective tissue growth factor: what's in a name?Mol Genet Metab. 2000 Sep-Oct;71(1-2):276-92. doi: 10.1006/mgme.2000.3059. Mol Genet Metab. 2000. PMID: 11001822 Review.
Cited by
-
Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?Biomedicines. 2024 Feb 7;12(2):385. doi: 10.3390/biomedicines12020385. Biomedicines. 2024. PMID: 38397987 Free PMC article. Review.
-
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment.Front Cell Dev Biol. 2023 Jan 30;11:1089068. doi: 10.3389/fcell.2023.1089068. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36793444 Free PMC article. Review.
-
PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia.J Oncol. 2022 Oct 14;2022:5896022. doi: 10.1155/2022/5896022. eCollection 2022. J Oncol. 2022. PMID: 36276286 Free PMC article.
-
Cathelicidin-3 Associated With Serum Extracellular Vesicles Enables Early Diagnosis of a Transmissible Cancer.Front Immunol. 2022 Mar 29;13:858423. doi: 10.3389/fimmu.2022.858423. eCollection 2022. Front Immunol. 2022. PMID: 35422813 Free PMC article.
-
Connective tissue growth factor expression hints at aggressive nature of colorectal cancer.World J Gastroenterol. 2022 Feb 7;28(5):547-569. doi: 10.3748/wjg.v28.i5.547. World J Gastroenterol. 2022. PMID: 35316957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous